There’s no denying that prescription opioids can be misused, abused, and diverted. And so, given these risks, there’s a ...
a Schedule II opioid, for rescue of breakthrough pain. Pending additional financing, Avenue aims to initiate the Phase 3 safety study as soon as feasible. The Company believes that the study can be ...
A clinical trial conducted at Arkansas Children's Hospital revealed a treatment helping children and adults better tolerate ...
Created in the 1960s, xylazine was approved by the Federal Drug Administration in 1972 as an animal-safe pharmaceutical. In ...
There are now almost 20,000 Food & Drug Administration (FDA) approved prescription drugs on the market in America — more than ...
As Humira biosimilars have taken over the market, CVS Caremark has created a new ploy to make money: the drug "rebate credit.
A recent NBC News report is shedding light on just how accessible Narcan is, after the FDA approved over-the-counter sales six months ago.
The U.S. Government Accountability Office said in January it would look into the agency’s oversight of medical device recalls, a little over a decade after a previous investigation by the watchdog ...
Medical researchers and doctors are seeing what is being described as the 'fourth wave' of opioid use, which includes ...
As the U.S. weathers its fourth wave of the opioid epidemic crisis, more people are turning to non-opioids — including a ...
The National Honor Society also announced that Padmanabhan has been selected as a NHS Scholarship semifinalist, and will be ...